Leslie J. Williams
Independent DirectorMs. Leslie J. Williams, BS, RN, MBA, is President & CEO of DaCapo Brainscience, Inc. She is Co-Founder, Chief Executive Officer, President and Director of hC Bioscience, Inc. Since January 2026, Ms. Williams has served as President and Chief Executive Officer and as a member of the board of directors of DaCapo Brainscience, Inc. She served as Independent Director at Windtree Therapeutics, Inc. since February 03, 2021 until August 13, 2024 and also its Lead Independent Director since June 22, 2023 until August 13, 2024. She serves as Operating Partner at Accelerator Life Science Partners since 2020. Ms. Williams has several years of industry experience in healthcare, management, commercial product development and marketing. She serves as Chief Executive Officer and President at BattellePharma. She served as Director, President and Chief Executive Officer of ImmusanT, Inc. since December 2010 until 2019. Ms. Williams founded ImmusanT, Inc. in 2010. Ms. Williams serves as an Independent Director of Ocular Therapeutix, Inc. since March 20, 2019 and advises life sciences companies and Universities on tech transfer, company formation, strategic collaborations and fundraising. Ms. Williams served as Chief Executive Officer and President of Ventaira Pharmaceuticals, Inc. since December 2004 and also served as its Director from 2004 until 2008. She has many years of industry experience in healthcare, management, commercial product development and marketing. Ms. Williams joined Ventaira Pharmaceuticals in 2003 in the dual roles of Vice President of Business and Commercial Development and served as its Chief Operating Officer since 2004. Ms. Williams served as Director of Marketing for INO Therapeutics, Inc., where she played a significant role in the NDA submission for INOmax. Ms. Williams pharmaceutical industry experience includes commercial positions at Merck and GlaxoSmithKline and drug-delivery and -monitoring experience at Datex-Ohmeda (formerly Ohmeda, Inc.). She was a Venture Partner at Battelle Ventures, where she sourced and evaluated deals and assisted early-stage technology companies with strategy, management, business development and M&A. Ms. Williams is a Member of the Board of Advisors of Life Science Cares, the Executive Board of the University of Iowa College of Pharmacy and of the Editorial Advisory Boards of Life Science Leader and the Journal of Advanced Therapies and Medical Innovation Sciences. She served as a Director of Hepregen Corporation and CDI Bioscience, Inc. She serves on the Boards of The Capital Network (TCN). She serves as a Mentor in the Boston University Kindle Program as well as Propel Careers. Among her many accomplishments, she helped orchestrate the New Drug Application submission to the FDA for INOmax for inhalation. She was responsible for the commercial aspects of INOmax's U.S. market introduction, from setting objectives and strategy to developing key constituency groups and expert advisory boards, as well as representing INO Therapeutics on Capitol Hill. She assisted with expansion of the INO-therapy platform into the European marketplace. She was recognized in 2006 as one of the top 100 leaders in life sciences by PharmaVOICE magazine. Ms. Williams is a member of the board of advisors of CSCRI (Coral Sea Clinical Research Institute), Life Science Cares, the executive board of the University of Iowa College of Pharmacy, founding member of Mass VX advisory committee and of the editorial advisory boards of the Life Science Leader and the Journal of Advanced Therapies and Medical Innovation Sciences. She was a Critical-Care Nurse at Duke University, Medical College of Virginia and at the University of Iowa. Ms. Williams has an MBA from Washington University, John Olin School of Business and a B.S. degree with honors in nursing from the University of Iowa.
Positions
- Company NameOcular Therapeutix, Inc.Stock CodeOCULPositionIndependent DirectorColleagues
- PUPravin U. DugelExecutive Chairman, President & CEO
- DNDonald NotmanChief Operating Officer (Leave of Absence)
- SMSteve MeyersChief Commercial Officer
- NKNadia K. WaheedChief Medical Officer
- JRJason RobinsCFO & Principal Accounting Officer
- CMCharles M. WardenLead Independent Director
- RLRichard L. LindstromIndependent Director
- MRMerilee RainesIndependent Director
